Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia

Brain

Volumn 124, Issue 4, 2001, Pages 769-783

  Munchau A ^a   Palmer, J D ^a   Dressler, D ^a   O'Sullivan, J D ^b   Tsang, K L ^a   Jahanshahi, M ^a   Quinn, N P ^a   Lees, A J ^b   Bhatia, K P ^a   Bhatia, Kailash P ^a,c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Botulinum toxin treatment failure; Cervical dystonia; Posterior ramisectomy; Selective peripheral denervation

Indexed keywords

BOTULINUM TOXIN;

ADULT; ARTICLE; CERVICAL SPINE; DENERVATION; DISABILITY; DISEASE SEVERITY; DYSPHAGIA; DYSTONIA; FEMALE; HEAD MOVEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE REINNERVATION; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SPINE SURGERY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREMOR;

EID: 0035045435     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.4.769     Document Type: Article

References (56)

1. Botulinum toxin treatment of spasmodic torticollis
2. Selective peripheral denervation: A surgical alternative in the treatment for spasmodic torticollis. Review of fifty-five patients
3. The surgical treatment of spasmodic torticollis
4. Assessing tremor severity
5. An inventory for measuring depression
6. An inventory for measuring clinical anxiety: Psychometric properties
7. Surgery as placebo: A quantitative study of bias
8. Selective peripheral denervation for spasmodic torticollis: Surgical technique, results, and observations in 260 cases
9. Observations and analysis of results in 131 cases of spasmodic torticollis after selective denervation
10. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
11. Selective peripheral denervation for the treatment of spasmodic torticollis
12. Selective peripheral denervation for spasmodic torticollis: Is the outcome predictable?
13. EuroQol: The current state of play
14. Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation
15. Management of spasmodic torticollis
16. Dysphagia after botulinum toxin injections for spasmodic torticollis: Clinical and radiologic findings
17. Clinical assessments of patients with cervical dystonia
18. Effect of thalamic lesions upon torticollis
19. An operation for the treatment of spasmodic torticollis
20. Botulinum toxin A antibodies in initial and delayed resistance to Botulinum toxin A therapy in cervical dystonia
21. EuroQol: A new facility for the measurement of health-related quality of life
22. Stress and coping in the explanation of psychological adjustment among chronically ill adults
23. Outcome of selective ramisectomy for botulinum toxin resistant torticollis
24. Bilateral microsurgical lysis of the spinal accessory nerve roots for treatment of spasmodic torticollis
25. Role of surgical anterior rhizotomies in the management of spasmodic torticollis
26. Change in pattern of muscle activity following botulinum toxin injections for torticollis
27. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis
28. Antitoxins and botulinum toxin treatment
29. Unilateral pallidal stimulation in cervical dystonia
30. Body concept, disability, and depression in patients with spasmodic torticollis
31. Response and immunoresistance to botulinum toxin injections
32. Change in the pattern of cervical dystonia might be the cause of benefit loss during botulinum toxin treatment
33. A new operation for spasmodic wry neck: Namely, division or exsection of the nerves supplying the posterior rotator muscles of the head
34. Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency
35. Symptomatic and functional outcome of surgical treatment of cervical dystonia
36. Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia
37. Observations on physiological and psychological functions of the ventral oral internal nucleus of the human thalamus
38. Treatment of cervical dystonia: A comparison of measures for outcome assessment
39. Surgical treatment of spasmodic torticollis
40. Stigma in patients with rectal cancer: A community study
41. The morphology of the sternomastoid and trapezius muscles
42. Muscle activity changes in spasmodic torticollis after botulinum toxin treatment
43. Intrameningeal division of the spinal accessory and roots of the upper cervical nerves for the treatment of spasmodic torticollis
44. Natural history of spasmodic torticollis, and effect of surgery
45. The McGill Pain Questionnaire: Major properties and scoring methods
46. A double blind trial of botulinum toxin 'A' in torticollis, with one year follow up
47. Polymyography combined with time-locked video recording (video-EMG) for pre-surgical assessment of patients with cervical dystonia
48. Perceived stigma among patients with spasmodic dysphonia
49. Torticollis
50. Spasmodic torticollis III: Surgical treatment
51. Trunk and head tremor as isolated manifestations of dystonia
52. Spasmodic torticollis: Results in 71 surgically treated patients
53. The Foerster-Dandy operation for the treatment of spasmodic torticollis
54. Double-blind study of botulinum toxin in spasmodic torticollis
55. Trick manoeuvres in cervical dystonia: Investigation of movement- and touch-related changes in polymyographic activity